Modulation of apomorphine-induced rotations in unilaterally 6- hydroxydopamine lesioned rats by cholinergic agonists and antagonists

Life Sciences

Volumn 60, Issue 22, 1997, Pages

  Gao, Zhan Guo ^a   Cui, Wen Yu ^a   Liu, Chuan Gui ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

6 hydroxydopamine; apomorphine; nicotine; oxotremorine; rotational behavior

Indexed keywords

APOMORPHINE; ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; NICOTINE; OXIDOPAMINE; OXOTREMORINE; SULPIRIDE;

ANIMAL BEHAVIOR; ARTICLE; CHOLINERGIC ACTIVITY; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; RECEPTOR SENSITIVITY; SUBSTANTIA NIGRA;

ANIMALS; APOMORPHINE; ATROPINE; BEHAVIOR, ANIMAL; CHOLINERGIC AGONISTS; CHOLINERGIC ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MECAMYLAMINE; NICOTINE; OXIDOPAMINE; OXOTREMORINE; RATS; RATS, WISTAR; SULPIRIDE;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0342762027     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00168-9     Document Type: Article

References (23)

1. V.H. SETHY, R.H. ROTH, M.J. KUHAR and M.H. VAN WOERT, Neuropharmacol. 12 819-823 (1973).
2. T. ARNFRED and A. RANDRUP, Acta Pharmacol. Toxicol. 26 384-394 (1968).
3. C.D. MARSDON, R.H.S. MINDHAM and A.V.P. MACKAY, The Psychopharmacology and Treatment of Schizophrenia, P.B. Bradley and S.R. Hirsh (Eds), 340-402, Oxford Press, New York (1986).
4. R.J. MILLER and C.R. HILEY, Nature, 248 596-597 (1974).
5. Y. KUBOTA, S. INAGAKI, S. SHIMADA, S. KITO, F. ECKENSTEIN and M. TOHYAMA, Brain Res. 413 179-184 (1987).
6. R. BERTORELLI and S. CONSOLO, J. Neurochem. 54 2145-2148 (1990).
7. D. FAGE and B. SCATTON, Eur. J Pharmacol 129 359-362 (1986).
8. E. FRIEDMAN, H.Y. WANG and P. BUTKERAIT, Neuropharmacol. 29 533-544 (1990).
9. H.Y. WANG, L.W. ZHOU, E. FRIEDMAN and B. WEISS, Neuropharmacol. 32 85-91 (1993).
10. C. LE MOINE, F. TISON and B. BLOCK, Neurosci. Lett. 177 248-252 (1990).
11. L.W. ZHOU, S.P. ZHANG, T.A. CONNELL and B. WEISS, Neurochem. Int. 22 301-311 (1993).
12. U. UNGERSTEDT, Acta Physiol. Scand. (Suppl) 367 69-93 (1971).
13. L.W. ZHOU, S.P. ZHANG, A. THOMAS, T.A. CONNELL, and B WEISS, J. Pharmacol. Exp. Ther. 264 824-830 (1993).
14. S.P. ZHANG, L.W. ZHOU and B. WEISS, J. Pharmacol. Exp. Ther. 271 1462-1470 (1994).
15. D.A. WELDON, L.C. CALABRESE and K.J. NICKLAUS, Pharmacol. Biochem. Behav. 19 813-820 (1983).
16. A. MAITI, K. SHAHID SALLES, S. GRASSI and L.G. ABOOD, Pharmacol. Biochem. Behav. 25 589-594 (1986).
17. G. PAXINOS and C. WATSON, The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney (1986).
18. C.A. HAWKINS and S.A. GREENFIELD, Behav. Brain Res. 48 159-163 (1992).
19. P. JENNER, S. BOYCE and D. MARSDEN, J. Neurol. Transm. (Suppl) 27 161-175 (1988).
20. Y.K. FUNG and Y.S. LAU, Pharmacol. Biochem. Behav. 32 221-226 (1989).
21. P.P. ROWELL, Neurosci. Lett. 189 171-175 (1995).
22. J.G. MODELL, R. TANDEN and T.P. BERESFORD, J. Clin. Psychopharmacol. 9 347-351 (1989).
23. J.J. HAGAN, J.A.D.M. TONNER, H. RICK, C.L.E. BROEKKAMP and A.M.L. VAN DELFT, Brain Res. 410 69-73 (1987).